Miles Wang
Miles Wang is a researcher at OpenAI who joined the company in March 2024 after studying computer science at Harvard University. He works on the reinforcement learning team and has co-authored research on scalable oversight, frontier evaluations, AI for science, and adversarial robustness. He is a co-author of papers including FrontierScience, which evaluates AI's ability to perform expert-level scientific tasks, and Persona Features Control Emergent Misalignment.
“Miles Wang, "an OpenAI researcher leaving to found an AI model company for drug discovery, is in talks to raise $200m" at a "$2b valuation" before even launching.”
“Miles Wang...is leaving the ChatGPT maker to launch a new startup focused on developing AI models for drug discovery.”
Source→“Miles Wang...is leaving the ChatGPT maker to launch a new startup focused on developing AI models for drug discovery...he may hit the ground running with a $200 million round of funding.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.